Alejandro González Veliz: Does Elevated Lp(a) Always Mean the Same Cardiovascular Risk?
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn about recent article by Niekbachsh Mohammadnia et al., published in JAMA Cardiology, adding:
“Does elevated Lp(a) always mean the same cardiovascular risk?
This new JAMA Cardiology study suggests the answer is no.
Among more than 43,000 individuals followed for over 13 years, IL-6 emerged as the only inflammatory biomarker that significantly modified the association between elevated Lp(a) and incident coronary artery disease.
Patients with both high Lp(a) and high IL-6 had substantially greater coronary risk, whereas elevated Lp(a) alone carried much less excess risk when IL-6 levels were low.
Interestingly, this interaction was not observed for aortic stenosis, suggesting different biological mechanisms despite Lp(a) being a shared risk factor.
These findings reinforce the concept that cardiovascular prevention may increasingly rely on combining lipid biology with inflammatory profiling, potentially helping identify those who could derive the greatest benefit from emerging Lp(a)-lowering and anti-inflammatory therapies.
What do you think will become the next essential biomarker in preventive cardiology: IL-6, hsCRP, or something else?”
Title: Lipoprotein(a), Inflammation, and Risk of Coronary Artery Disease and Aortic Valve Stenosis
Authors: Niekbachsh Mohammadnia, Linke Li, Daniel Ezzat, Zhi Yu, Vineet K. Raghu, Jennifer L. Halford, Niels P. Riksen, Pradeep Natarajan, Jan H. Cornel, Michael C. Honigberg, Saloua El Messaoudi

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 05:57Lance Reed: Specialized Blood Components and Clinical Samples for Research and Diagnostics
-
Nov 20, 2026, 05:41Sundas Anjum: Community Engagement and Blood Donation for Thalassemia Care
-
Nov 20, 2026, 05:24A Celebration of Unity and Dedication in Hemophilia Care – Hemophilia Society Mumbai Chapter
-
Nov 20, 2026, 05:09Farhad Sheikh: Prasugrel vs Ticagrelor in Acute Coronary Syndromes
-
Nov 20, 2026, 05:02Jason Acker: Appointed as the Next Editor-in-Chief of Vox Sanguinis
-
Nov 20, 2026, 04:58Sabri Kemahli: International Society of Hematology Celebrates 80 Years of Hematology with Special Webinar
-
Nov 20, 2026, 04:46Alessandra Bosch: Swiss Haemophilia Network Wins Research Grant
-
Nov 20, 2026, 04:41Courtney Lawrence: HLA Antibodies and Platelet Transfusion Refractoriness in Hispanic Patients
-
Nov 20, 2026, 04:24Kamand Haeri: Platelet Function Testing by Flow Cytometry in Patients with BDUC at SOHC 2026